Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19
1 other identifier
interventional
120
1 country
1
Brief Summary
The Post-COVID syndrome is a COVID-19 sequelae disease with high individual burden. We conduct a prospective, two-arm, randomized-controlled intervention study with embedded qualitative and physiological sub-studies in a mixed-methods design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedStudy Start
First participant enrolled
September 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 23, 2024
January 1, 2024
1.8 years
August 17, 2023
January 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Short Form 36 (SF-36), Physical Functioning Scale
The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Baseline, 10 weeks
Secondary Outcomes (19)
Short Form 36 (SF-36)
Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks
DePaul Post-Exertional Malaise Questionnaire (DSQ-PEM)
Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks
Post-COVID-Syndrom (PCS) Score
Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks
Chalder Fatigue Scale (CFS)
Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks
Quality of life (EQ-5D-5L)
Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks
- +14 more secondary outcomes
Other Outcomes (3)
Qualitative data
Week 10
Sub-study: Focus group interviews with physicians
Week 10
Sub-study: biosignal characteristics
Baseline, week 10
Study Arms (2)
Complementary and Integrative Medicine online intervention, routine care and book
EXPERIMENTALRoutine care and book
ACTIVE COMPARATORInterventions
The online program takes place in a multiprofessionally guided online group setting once a week for up to 180 minutes (including several breaks) over a period of 10 weeks: * Basic principles of a plant-based whole-food nutrition * Procedures of hydrotherapy according to Kneipp * Self-help strategies (e.g. teas, wraps, compresses etc.) * Methods of mind-body medicine (mindfulness, meditation, breathing, yoga etc.) * Methods of extended Complementary and Integrative Medicine (e.g. acupressure) It is recommended to practice a part of the taught exercises at home for about 30 minutes daily. In addition, the patients receive a book for the treatment of post-covid syndrome complaints. Group 1 additionally uses the already existing routine care (e.g. general practitioner).
Participants in the second study arm receive routine care, e.g. from their general practitioner. In addition, the patients receive the same book as group 1 for the treatment of post-covid syndrome complaints. The participants of the second study arm will be offered to participate in the Complementary and Integrative Medicine online intervention after 4 months within the study.
Eligibility Criteria
You may qualify if:
- Acute SARS-CoV2 infection at least 12 weeks ago (documented by PCR test results or SARS-CoV-2 antibodies)
- History of chronic fatigue (after SARS-CoV-2 infection)
- Numerical Rating Scale (NRS, 0-10 points, 0 = not able to exercise at all; 10 = full exercise capacity) physical exercise capacity of max. 6 points ("What is your physical exercise capacity on average over the last 7 days?")
- Short Form-36 Physical Function Subscale (SF-36 PFS) of maximum 65 points
- Patient are technically equipped enough to participate in the online intervention and willing to follow the study procedure to perform the online intervention at home
You may not qualify if:
- Fatigue already present before SARS-CoV-2 infection
- Presence of severe post-exertional malaise (PEM) (according to DSQ-PEM tool question 7 OR 8 with yes AND \>14h condition worsening)
- Other underlying conditions leading to symptoms of chronic fatigue, such as unstable mental illness, oncological disease(s), MS, fibromyalgia, and substance abuse
- Other serious underlying medical conditions, such as severe pulmonary, cardiac, psychiatric, or infectious diseases that could interfere with study participation or affect results • Ongoing opioid therapy or opioid therapy in the week prior to study entry
- Regular use of cannabinoids or other illicit drugs in the month prior to or during the study
- Restarting or discontinuing psychotherapy during study participation in the 6 weeks prior to study entry
- Pregnancy or breastfeeding
- Participation in another clinical intervention study during study participation 1
- Regular use of Complementary and Integrative Medicine self-help measures (e.g. meditation, Kneipp hydrotherapiy, etc.) within the study period
- Current pension procedure or planned claiming of a pension procedure due to disability
- Planned rehabilitation measures during study participation due to post-COVID syndrome
- Family physicians and general practitioners
- Regular outpatient care of patients with post-covid syndrome
- Willingness in principle to participate in a 2-hour interview on-site or online
- No previous care of post-covid patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
Berlin, 14109, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 22, 2023
Study Start
September 4, 2023
Primary Completion
July 1, 2025
Study Completion
December 1, 2025
Last Updated
January 23, 2024
Record last verified: 2024-01